Full Text View
Tabular View
No Study Results Posted
Related Studies
Pharmacologic Relapse Prevention for Alcoholic Smokers
This study has been completed.
Study NCT00000457   Information provided by National Institute on Alcohol Abuse and Alcoholism (NIAAA)
First Received: November 2, 1999   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alcoholism
Smoking
More general conditions related to this trial
Alcohol-Related Disorders
Disorders of Environmental Origin
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
nicotine replacement patch
bupropion (Wellbutrin)
Additional drug interventions recognized in this trial
Bupropion
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute on Alcohol Abuse and Alcoholism (NIAAA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services